The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Geriatric assessment in older patients with non-small cell lung cancer: Insights from a cluster-randomized, phase III trial—ENSURE-GA study (NEJ041/CS-Lung001).
 
Naoki Furuya
No Relationships to Disclose
 
Nobuhiro Kanaji
No Relationships to Disclose
 
Keiki Yokoo
Honoraria - AstraZeneca; Boehringer Ingelheim; Bristol Myers Squibb Foundation; Chugai/Roche; Lilly; Merck; MSD K.K; Nippon Kayaku; Takeda
 
Takashi Yanagawa
No Relationships to Disclose
 
Hiroshi Yamamoto
Honoraria - AstraZeneca; Bristol-Myers Squibb; Chugai/Roche; Daiichi Sankyo; GlaxoSmithKline; Kyorin; Kyowa Kirin; MSD; Nihonkayaku; Novartis
 
Koichi Takayama
Honoraria - AstraZeneca; Boehringer Ingelheim; Chugai/Roche; Daiichi Sankyo; Lilly; MSD; Ono Pharmaceutical; Shionogi; Taiho Pharmaceutical
Research Funding - Taiho Pharmaceutical
 
Shigeo Kawase
No Relationships to Disclose
 
Kazuto Matsunaga
No Relationships to Disclose
 
Kenichi Takeda
No Relationships to Disclose
 
Hiromi Nagashima
No Relationships to Disclose
 
Tomohiro Sakamoto
Speakers' Bureau - Amgen; AstraZeneca; Chugai Pharma; Daiichi Sankyo; Janssen; Kyowa Kirin; Lilly; Merck; MSD; Novartis; Ono Pharmaceutical; Pfizer; Taiho Pharmaceutical; Takeda
 
Takamasa Hotta
No Relationships to Disclose
 
Yuichi Takiguchi
Honoraria - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb Japan; Chugai Pharma; Daiichi Sankyo; Kyowa Kirin International; Lilly; Novartis; Ono Pharmaceutical; Pfizer; Taiho Pharmaceutical
Research Funding - Abbvie; AstraZeneca; Boehringer Ingelheim; Chugai Pharma; Daiichi Sankyo; Lilly; MSD Oncology; Taiho Pharmaceutical
 
Hitomi Nogawa
No Relationships to Disclose
 
Yasuhiko Nishioka
No Relationships to Disclose
 
Kunihiko Kobayashi
Consulting or Advisory Role - Daiichi Sankyo/UCB Japan
Speakers' Bureau - AstraZeneca
Research Funding - Zeria Pharmaceutical Co. (Inst)
Patents, Royalties, Other Intellectual Property - I am a co-inventor on Japanese patent # 7422498; Peptide of inhibiting cell migration, cell invasion, and cancer metastasis.
 
Takeshi Isobe
Speakers' Bureau - Boehringer Ingelheim
 
Yukari Tsubata
Speakers' Bureau - AstraZeneca; Bristol-Myers Squibb Japan; Chugai Pharma; Daiichi Sankyo; Kyowa Kirin International; Pfizer; Taiho Pharmaceutical; Takeda
Research Funding - AstraZeneca (Inst); Daiichi Sankyo (Inst); Ono Pharmaceutical (Inst)